Hemispherx Biopharma Inc (HEB)

HEB on American Stock Exchange

0.27USD
6 May 2015
Change (% chg)

$0.00 (+1.50%)
Prev Close
$0.27
Open
$0.26
Day's High
$0.28
Day's Low
$0.26
Volume
3,745,527
Avg. Vol
1,809,598
52-wk High
$0.40
52-wk Low
$0.21

HEB

Chart for HEB

About

Hemispherx Biopharma, Inc. is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company focuses on two core pharmaceutical technology platforms Ampligen and Alferon... (more)

Overall

Beta: 1.30
Market Cap(Mil.): $54.85
Shares Outstanding(Mil.): 215.10
Dividend: --
Yield (%): --

Financials

  HEB Industry Sector
P/E (TTM): -- 188.47 40.23
EPS (TTM): -0.09 -- --
ROI: -64.23 -0.64 15.26
ROE: -64.27 -2.50 16.08
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks